results of retatrutide weight loss phase 2 trial Retatrutide: A Triple Agonist Shaping the Future Metabolic Care 🧬 RETATRUTIDE & MUSCLE PRESERVATION:

TripleHormone-Receptor Agonist Retatrutide

How Common Are These Reactions and Who Is at Risk Injection site reactions were among the more common adverse events in Phase 2 trials, generally mild to moderate

Results demonstrated clear dose-dependent weight loss with a remarkably linear progression

Monthly $179/mo 2.5mg/5mg vial billed monthly All treatments include: High potency, 3rd party lab tested Personalized protocols from licensed physicians Free discreet shipping every order Ongoing provider support & check-ins Get started Best Value Quarterly $149/mo 2.5mg/5mg vial billed every 3 months Everything in monthly, plus: Priority shipping & processing Dedicated care coordinator Complimentary dosage adjustments Save up to 15% vs monthly billing Get started Patient Stories There's a reason people are raving about us Join thousands of patients who have trusted Zera Health to transform their lives